Definitive Contract HHSN261201400021C
Award Date
9/16/14
Potential Completion Date
6/15/15
Potential Value
$208K
Federal Agency
National Cancer Institute
Awardee
Akina, Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Lafayette, IN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
22
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, HHSN271201600200P, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services. The $114,640 firm-fixed-price purchase order was awarded to Ingenious Targeting Laboratory Inc., a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business. The contract is set aside for small businesses and supports the use of mouse knockout models to determine the function of...
<p>The National Cancer Institute (NCI) awarded a Small Business Innovation Research (SBIR) Phase 2 contract worth $299,920.00 to Akrivis Technologies, LLC, a minority-owned, small disadvantaged business in Cambridge, MA. The contract, which is a definitive, firm-fixed-price contract, supports SBIR Topic 314 and has an ultimate completion date of October 21, 2016. The contract is set aside for total small business participation.</p>
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a civilian agency, to Rana Bioscience, Inc., a minority-owned and Asian-Pacific American-owned for-profit small business manufacturer. The contract, valued at $149,634, is for the development of an expression system to synthesize glycoproteins with defined O-glycan structures, under SBIR Topic 269. As a Phase I SBIR award, this contract is focused on the initial feasibility and...
<p>This is a federal contract awarded by the National Cancer Institute, a civilian agency, to Transgenex Nanobiotech Inc., a minority-owned small business. The contract, valued at $224,999.00, is for a Small Business Innovation Research (SBIR) Program Phase I action. The contract is a definitive, firm-fixed-price contract with a completion date of September 15, 2015. This contract is set aside for small businesses.</p>
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to ABI Scientific Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract is for the delivery of 100 units of Adherent Cell Expression Media 250 ML at a total potential value of $12,340.00. The contract was awarded on January 30, 2018, with a completion date of January 30, 2019....
This is a $992,088.91 Phase II Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) Department of Health and Human Services (HHS), to Rockland Immunochemicals Inc., a for-profit small business corporation. The contract is for the development of a "Pharmacodynamic Assay for AKT for Use with PI3K/AKT/mTOR Inhibitors" under SBIR Topic 229. As a Phase II SBIR award, this follows a previous Phase I...
This federal contract award, with an ID of 75N91023D00010|75N91024F00001, was issued by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract, which is not set aside, has a ceiling value of $1,866,116.00 and a completion date of September 17, 2026. The scope of the contract includes the production of a drug substance, conversion of the drug substance to a drug product, filling the drug product into applicators for clinical...
This is a federal contract award from the Department of Health and Human Services (HHS) to Ascentgene Inc., a Minority Owned, For Profit, Asian-Pacific American Owned small business. The contract, valued at $219,821.00, is for the Small Business Innovation Research (SBIR) Program Phase I action to develop "Innovative Methods for Manufacturing Safe, Effective Cancer Therapeutics". The contract is a Definitive, Firm Fixed Price contract with a completion date of June 14, 2010. This award...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Lakepharma, Inc., a minority-owned, for-profit biopharmaceutical contract development and manufacturing organization (CDMO). The $20,000 contract is for the "heavy and light humanization of 1B3 MAB", which involves antibody humanization services to support NIAID's medical research and healthcare mission. The...
This is a $25,956.00 firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Takara Bio USA, Inc., a for-profit manufacturer of specialized biomedical products and services. The contract is for the period of February 24, 2016 to July 15, 2016, and does not have a small business set-aside designation. Takara Bio USA, Inc. is a prime contractor providing the National Cancer Institute with research tools...